Form D · Private Equity Fund

Blackstone Life Sciences VI Access Fund (Offshore), L.P.

New York, NY · CIK 0002087835

Offering snapshot reported Sep 24, 2025 · SEC filing

Reported sold
$89.1M
Offering amount: $89.1M
Investors reported
189
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Sep 22, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 24, 2025Initial$89,088,000No comparison189SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$283K
Finders' fees
$0
Form D file number
021-558491

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Merrill Lynch, Pierce, Fenner & Smith Incorporated7691

Source: Form D, filed Sep 24, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Asterion Fund Services (Offshore) Ltd. Promoter
Scott Huff Executive
I Capital Alternative Investments Llc Executive
Maples Fs Directors Limited Executive
Edward Truitt, Jr. Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
One Grand Central Place 60 East 42 Nd Street 26 Th Floor
New York, NY, 10165